论文部分内容阅读
目的:探讨中低位直肠癌患者在新辅助治疗后行腹腔镜手术的安全性、可行性。方法:回顾性分析41例新辅助治疗后行腹腔镜手术的中低位直肠癌患者(观察组)与同期48例单纯腹腔镜手术(对照组)中低位直肠癌患者的临床资料。比较两组患者的手术相关指标、术后恢复情况及术后并发症发生率。结果:两组患者术前条件具有可比性,两组均无手术相关死亡患者。观察组淋巴结清除数明显低于对照组(8.3 vs.15.2,P<0.01),其余手术相关指标、术后恢复情况以及术后并发症发生率两组间差异均无统计学意义(均P>0.05)。结论:腹腔镜直肠癌根治术在行新辅助治疗后的中低位直肠癌患者中应用是安全、可行的。
Objective: To investigate the safety and feasibility of laparoscopic surgery in patients with low and middle rectal cancer after neoadjuvant therapy. Methods: The clinical data of 41 low and middle rectal cancer patients undergoing neoadjuvant laparoscopic surgery (observation group) and 48 low - lying rectal cancer patients undergoing simple laparoscopic surgery (control group) were retrospectively analyzed. Surgical related indicators, postoperative recovery and incidence of postoperative complications were compared between the two groups. Results: Preoperative conditions were comparable between the two groups, with no patient-related deaths in either group. The number of lymph node clearance in the observation group was significantly lower than that in the control group (8.3 vs.15.2, P <0.01). There was no significant difference between the two groups in the other operation related indexes, postoperative recovery and postoperative complication rate (all P> 0.05). Conclusions: The application of laparoscopic radical mastectomy in low and middle rectal cancer patients after neoadjuvant therapy is safe and feasible.